FR3024036B1 - VOLATILE COMPOUNDS FOR THE TREATMENT OF NEUROPALUDISM - Google Patents

VOLATILE COMPOUNDS FOR THE TREATMENT OF NEUROPALUDISM

Info

Publication number
FR3024036B1
FR3024036B1 FR1457112A FR1457112A FR3024036B1 FR 3024036 B1 FR3024036 B1 FR 3024036B1 FR 1457112 A FR1457112 A FR 1457112A FR 1457112 A FR1457112 A FR 1457112A FR 3024036 B1 FR3024036 B1 FR 3024036B1
Authority
FR
France
Prior art keywords
neuropaludism
treatment
volatile compounds
volatile
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1457112A
Other languages
French (fr)
Other versions
FR3024036A1 (en
Inventor
Vical Francoise Benoit-
Travers Marie- Laure Nicolau-
Benoit Witkowski
Xavier Iriart
Antoine Berry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Toulouse
Universite Toulouse III Paul Sabatier
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Toulouse
Universite Toulouse III Paul Sabatier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Centre Hospitalier Universitaire de Toulouse, Universite Toulouse III Paul Sabatier filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1457112A priority Critical patent/FR3024036B1/en
Priority to PCT/EP2015/066926 priority patent/WO2016012560A1/en
Publication of FR3024036A1 publication Critical patent/FR3024036A1/en
Application granted granted Critical
Publication of FR3024036B1 publication Critical patent/FR3024036B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1457112A 2014-07-23 2014-07-23 VOLATILE COMPOUNDS FOR THE TREATMENT OF NEUROPALUDISM Expired - Fee Related FR3024036B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1457112A FR3024036B1 (en) 2014-07-23 2014-07-23 VOLATILE COMPOUNDS FOR THE TREATMENT OF NEUROPALUDISM
PCT/EP2015/066926 WO2016012560A1 (en) 2014-07-23 2015-07-23 Volatile compounds for treating cerebral malaria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1457112A FR3024036B1 (en) 2014-07-23 2014-07-23 VOLATILE COMPOUNDS FOR THE TREATMENT OF NEUROPALUDISM

Publications (2)

Publication Number Publication Date
FR3024036A1 FR3024036A1 (en) 2016-01-29
FR3024036B1 true FR3024036B1 (en) 2016-08-05

Family

ID=51610345

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1457112A Expired - Fee Related FR3024036B1 (en) 2014-07-23 2014-07-23 VOLATILE COMPOUNDS FOR THE TREATMENT OF NEUROPALUDISM

Country Status (2)

Country Link
FR (1) FR3024036B1 (en)
WO (1) WO2016012560A1 (en)

Also Published As

Publication number Publication date
FR3024036A1 (en) 2016-01-29
WO2016012560A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
IL247449A0 (en) Ether compounds for treatment of complement mediated disorders
MA39748A (en) CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
DK3125875T3 (en) INHALABLE RAPAMYCINFORMULATION FOR THE TREATMENT OF AGING-RELATED CONDITIONS
DK3556775T3 (en) ANTI-LAG-3 ANTIBODIES FOR THE TREATMENT OF HEMATOLOGICAL MALIGNITIES
DK3134530T3 (en) TREATMENT OF HYPERBILIR RUBINY
MA41449A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCERS
DK3240612T3 (en) PROCEDURES FOR THE TREATMENT OF RHINTH DISEASES
DK3102213T3 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
DK3148529T3 (en) COMPOUNDS FOR THE TREATMENT OF BRAIN CANCER
SG11201609652RA (en) Treatment of polybacterials infections
HK1244485A1 (en) Combinations for the treatment of neuroblastoma
FI20146127A (en) Process for the preparation of hydrocarbons
MA41123A (en) POLYTHERAPY FOR CANCER TREATMENT
MA42999A (en) POLYTHERAPY FOR THE TREATMENT OF MALIGNITIES
FI20155237A (en) Device for cleaning the inside of the pipe
PL3122349T3 (en) Compositions for the treatment of autodigestion
DK3578179T3 (en) PROCESS FOR THE PREPARATION OF CYCLIC DEPSIPEPTIDES
DK3120153T3 (en) CELLULAR-BASED PROCEDURE FOR DETERMINING THE POSSIBILITY OF DEFIBROTIME
DK3209295T3 (en) PROCEDURES FOR THE TREATMENT OF EYE DISORDERS
DK3096775T3 (en) SOCS mimetics for the treatment of diseases
FR3022129B1 (en) BATHTUB OF PUERICULTURE
MA41202A (en) CROSS-LINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES
SG11201702700UA (en) Methods for the treatment of peri-implantitis
DK3200783T3 (en) TREATMENT OF ERYTROMELALGY
FR3024647B1 (en) TRANSAT OF PUERICULTURE

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Search report ready

Effective date: 20160129

PLFP Fee payment

Year of fee payment: 3

ST Notification of lapse

Effective date: 20180330